Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P02766: Variant p.Ser97Tyr

Transthyretin
Gene: TTR
Feedback?
Variant information Variant position: help 97 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Serine (S) to Tyrosine (Y) at position 97 (S97Y, p.Ser97Tyr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and polar (S) to large size and aromatic (Y) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In AMYLD1; amyloid polyneuropathy. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 97 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 147 The length of the canonical sequence.
Location on the sequence: help GLTTEEEFVEGIYKVEIDTK S YWKALGISPFHEHAEVVFTA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         GLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTA

Chimpanzee                    GLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTA

Mouse                         GLTTDEKFVEGVYRVELDTKSYWKTLGISPFHEFADVVFTA

Rat                           GLTTDEKFTEGVYRVELDTKSYWKALGISPFHEYAEVVFTA

Pig                           GLTTDEKFVEGIYKVELDTKSYWKALGISPFHEYAEVVFTA

Bovine                        GLTTEDKFVEGLYKVELDTKSYWKSLGISPFHEFAEVVFTA

Rabbit                        GLTTSEKFVEGVYKVELDTKSYWKALGISPFHEYAEVVFTA

Sheep                         GLTTEDKFVEGLYKVELDTKSYWKSLGISPFHEYAEVVFTA

Chicken                       ELTTEEQFVEGVYRVEFDTSSYWKGLGLSPFHEYADVVFTA

Xenopus laevis                NLTTDEQFTEGVYKIEFATKAFWGKLGLSPFHEYVDVVFTA

Xenopus tropicalis            NIITDEQFTEGVYKIEFATKTFWRKLGLSPFHEYVDVVFSA
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 21 – 147 Transthyretin
Mutagenesis 107 – 107 F -> M. Loss of tetramerization; when associated with M-130.
Helix 95 – 101



Literature citations
Identification of a new hereditary amyloidosis prealbumin variant, Tyr-77, and detection of the gene by DNA analysis.
Wallace M.R.; Dwulet F.E.; Williams E.C.; Conneally P.M.; Benson M.D.;
J. Clin. Invest. 81:189-193(1988)
Cited for: VARIANT AMYLD1 TYR-97; Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy.
Reilly M.M.; Adams D.; Booth D.R.; Davis M.B.; Said G.; Laubriat-Bianchin M.; Pepys M.B.; Thomas P.K.; Harding A.E.;
Brain 118:849-856(1995)
Cited for: VARIANTS AMYLD1 MET-50; ASN-55; ALA-69; ARG-70; ALA-80; TYR-97 AND GLN-109; Identification of transthyretin variants by sequential proteomic and genomic analysis.
Bergen H.R. III; Zeldenrust S.R.; Butz M.L.; Snow D.S.; Dyck P.J.; Dyck P.J.B.; Klein C.J.; O'Brien J.F.; Thibodeau S.N.; Muddiman D.C.;
Clin. Chem. 50:1544-1552(2004)
Cited for: VARIANTS SER-26; CYS-53 AND ALA-114; VARIANTS AMYLD1 GLU-67; HIS-78; ALA-80 AND TYR-97; IDENTIFICATION BY MASS SPECTROMETRY; Genetic microheterogeneity of human transthyretin detected by IEF.
Altland K.; Benson M.D.; Costello C.E.; Ferlini A.; Hazenberg B.P.C.; Hund E.; Kristen A.V.; Linke R.P.; Merlini G.; Salvi F.; Saraiva M.J.; Singer R.; Skinner M.; Winter P.;
Electrophoresis 28:2053-2064(2007)
Cited for: VARIANTS AMYLD1 PRO-32; ILE-40; SER-44; ALA-50; MET-50; LEU-53; VAL-53; PRO-56; THR-65; ALA-67; ALA-69; ILE-69; ALA-80; LEU-84; LEU-88; ALA-91; TYR-97; PHE-98; SER-104; ASN-104; THR-104; ALA-114; GLY-117; ASN-126; MET-127; VAL-127; MET-131 AND ILE-142; VARIANTS ILE-33; SER-121 AND THR-129; VARIANT CHICAGO MET-139;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.